Literature DB >> 1658051

Exclusion of linkage between the collagenase gene and generalized recessive dystrophic epidermolysis bullosa phenotype.

A Hovnanian1, P Duquesnoy, S Amselem, C Blanchet-Bardon, M Lathrop, L Dubertret, M Goossens.   

Abstract

Generalized recessive dystrophic epidermolysis bullosa (RDEB) is a severe inherited autosomal disease characterized by dermolytic blister formation. Enhanced collagenase and/or abnormal collagenase have been reported in skin from affected patients, suggesting that collagenase could be responsible for the absence of anchoring fibrils in this disorder. We used a genetic linkage approach to test the hypothesis that this disease is due to a defect in the collagenase gene in nine affected families. Analysis of amplified genomic DNA fragments of the collagenase gene by means of denaturing gradient gel electrophoresis (DGGE) allowed us to detect intragenic polymorphisms, which were subsequently characterized by direct genomic sequencing. Segregation analysis of these polymorphic sites showed exclusion of linkage between the collagenase gene and generalized RDEB phenotype in a family with consanguineous parents and three affected children. However, the possibility of linkage with the collagenase gene in the other eight families tested could not be excluded. The genetic markers described here provide a tool for investigating genetic linkage in other affected families. Overall, our results show that generalized RDEB can be caused by a defect in a gene other than the collagenase gene, and support the hypothesis that the genetic defect lies in abnormal anchoring fibril formation.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1658051      PMCID: PMC295711          DOI: 10.1172/JCI115489

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  41 in total

1.  Studies on the pathogenesis of epidermolysis bullosa.

Authors:  R W PEARSON
Journal:  J Invest Dermatol       Date:  1962-12       Impact factor: 8.551

2.  Recessive dystrophic epidermolysis bullosa: evidence for an altered collagenase in fibroblast cultures.

Authors:  E A Bauer
Journal:  Proc Natl Acad Sci U S A       Date:  1977-10       Impact factor: 11.205

3.  Collagenase in recessive dystrophic epidermolysis bullosa.

Authors:  E A Bauer
Journal:  Ann N Y Acad Sci       Date:  1985       Impact factor: 5.691

4.  Antenatal diagnosis of recessive dystrophic epidermolysis bullosa: collagenase expression in cultured fibroblasts as a biochemical marker.

Authors:  E A Bauer; M D Ludman; J D Goldberg; R L Berkowitz; K A Holbrook
Journal:  J Invest Dermatol       Date:  1986-11       Impact factor: 8.551

5.  Mutations in the catalytic domain of human coagulation factor IX: rapid characterization by direct genomic sequencing of DNA fragments displaying an altered melting behavior.

Authors:  O Attree; D Vidaud; M Vidaud; S Amselem; J M Lavergne; M Goossens
Journal:  Genomics       Date:  1989-04       Impact factor: 5.736

6.  The structure of the human skin fibroblast collagenase gene.

Authors:  I E Collier; J Smith; A Kronberger; E A Bauer; S M Wilhelm; A Z Eisen; G I Goldberg
Journal:  J Biol Chem       Date:  1988-08-05       Impact factor: 5.157

7.  Human fibroblast collagenase. Complete primary structure and homology to an oncogene transformation-induced rat protein.

Authors:  G I Goldberg; S M Wilhelm; A Kronberger; E A Bauer; G A Grant; A Z Eisen
Journal:  J Biol Chem       Date:  1986-05-15       Impact factor: 5.157

8.  Homozygosity mapping: a way to map human recessive traits with the DNA of inbred children.

Authors:  E S Lander; D Botstein
Journal:  Science       Date:  1987-06-19       Impact factor: 47.728

9.  Lack of type VII collagen in unaffected skin of patients with severe recessive dystrophic epidermolysis bullosa.

Authors:  L Bruckner-Tuderman; S Rüegger; B Odermatt; Y Mitsuhashi; U W Schnyder
Journal:  Dermatologica       Date:  1988

10.  A perspective on the role of collagenase in recessive dystrophic epidermolysis bullosa.

Authors:  E A Bauer; M Tabas
Journal:  Arch Dermatol       Date:  1988-05
View more
  7 in total

Review 1.  Molecular genetics of the cutaneous basement membrane zone. Perspectives on epidermolysis bullosa and other blistering skin diseases.

Authors:  J Uitto; A M Christiano
Journal:  J Clin Invest       Date:  1992-09       Impact factor: 14.808

2.  Genetic linkage of recessive dystrophic epidermolysis bullosa to the type VII collagen gene.

Authors:  A Hovnanian; P Duquesnoy; C Blanchet-Bardon; R G Knowlton; S Amselem; M Lathrop; L Dubertret; J Uitto; M Goossens
Journal:  J Clin Invest       Date:  1992-09       Impact factor: 14.808

3.  Genetic linkage of type VII collagen (COL7A1) to dominant dystrophic epidermolysis bullosa in families with abnormal anchoring fibrils.

Authors:  M Ryynänen; J Ryynänen; S Sollberg; R V Iozzo; R G Knowlton; J Uitto
Journal:  J Clin Invest       Date:  1992-03       Impact factor: 14.808

Review 4.  Epidermolysis bullosa: hereditary skin fragility diseases as paradigms in cell biology.

Authors:  R A Eady; M G Dunnill
Journal:  Arch Dermatol Res       Date:  1994       Impact factor: 3.017

Review 5.  Molecular basis for the dystrophic forms of epidermolysis bullosa: mutations in the type VII collagen gene.

Authors:  J Uitto; A M Christiano
Journal:  Arch Dermatol Res       Date:  1994       Impact factor: 3.017

6.  Genetic linkage to the type VII collagen gene (COL7A1) in 26 families with generalised recessive dystrophic epidermolysis bullosa and anchoring fibril abnormalities.

Authors:  M G Dunnill; A J Richards; G Milana; F Mollica; D Atherton; I Winship; M Farrall; L al-Imara; R A Eady; F M Pope
Journal:  J Med Genet       Date:  1994-10       Impact factor: 6.318

7.  Investigation of the relationship between osteoporosis and the collagenase gene by means of polymorphism of the 5'upstream region of this gene.

Authors:  L M Thiry-Blaise; A N Taquet; J Y Reginster; B Nusgens; P Franchimont; C M Lapière
Journal:  Calcif Tissue Int       Date:  1995-01       Impact factor: 4.333

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.